Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

53 trials with published results (10%)

Research Maturity

302 completed trials (59% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.2%

11 terminated out of 509 trials

Success Rate

96.5%

+10.0% vs benchmark

Late-Stage Pipeline

20%

102 trials in Phase 3/4

Results Transparency

18%

53 of 302 completed with results

Key Signals

53 with results96% success11 terminated

Data Visualizations

Phase Distribution

326Total
Not Applicable (169)
Early P 1 (7)
P 1 (15)
P 2 (33)
P 3 (28)
P 4 (74)

Trial Status

Completed302
Unknown127
Recruiting29
Not Yet Recruiting15
Active Not Recruiting13
Terminated11

Trial Success Rate

96.5%

Benchmark: 86.5%

Based on 302 completed trials

Clinical Trials (509)

Showing 20 of 20 trials
NCT07260552Not Yet RecruitingPrimary

Rapid Engagement for Solutions to Population and Outcomes Through Networked Dialogue for Coronary Heart Disease

NCT05830318Completed

Usability and Acceptability Study of the P-STEP Mobile Application

NCT02044250Phase 4CompletedPrimary

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)

NCT07549282Phase 4Not Yet RecruitingPrimary

Use Dexmedetomidine To Protect Myocardial Injury Evaluation

NCT07544459Not ApplicableCompletedPrimary

Mindfulness-based Stress Reduction Combined With Aerobic Training in Cardiac Rehabilitation After Percutaneous Coronary Intervention: A Dual Impact on Kinesiophobia and Heart Rate Variability

NCT03852082Active Not RecruitingPrimary

Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention

NCT06031844Phase 2CompletedPrimary

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP

NCT06097663Phase 2CompletedPrimary

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

NCT07507162Not ApplicableNot Yet Recruiting

Timing of Endoscopy in Coronary Heart Disease Patients Taking Antiplatelet Drugs With Acute Non-variceal Upper Gastrointestinal Bleeding

NCT07493603Phase 1RecruitingPrimary

A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease

NCT06816693CompletedPrimary

Exploratory Study of the Usability, Feasibility, and Perception for Tele-cardiac Rehabilitation (Tele-CR) Program

NCT07468955Not ApplicableCompleted

Impact of Cardiac Rehabilitation on Patient Outcomes

NCT05282680Active Not Recruiting

The Hong Kong Diabetes Biobank

NCT06494163Not ApplicableRecruiting

Exercise Training in Women With Heart Disease 2

NCT07451873RecruitingPrimary

Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

NCT07165678Not ApplicableNot Yet RecruitingPrimary

CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)

NCT05937230Active Not RecruitingPrimary

Drug-coated Balloons and Drug-eluting Stents in Diabetic Patients

NCT05133921CompletedPrimary

The Clinical Efficacy and Safety of Drug-coated Balloon

NCT07378228Not ApplicableCompletedPrimary

Weak Pulse at Yang and Wiry Pulse at Yin Theory

NCT07373119Not ApplicableEnrolling By InvitationPrimary

Improving Frailty in Patients With Stable Ischemic Heart Disease

Scroll to load more

Research Network

Activity Timeline